Equities

Generic Sweden AB (publ)

GENI:STO

Generic Sweden AB (publ)

Actions
  • Price (SEK)59.90
  • Today's Change1.90 / 3.28%
  • Shares traded7.34k
  • 1 Year change+14.97%
  • Beta1.1391
Data delayed at least 15 minutes, as of May 20 2022 17:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • GENI:STO price moved over +4.99% to 61.00
  • GENI:STO price falls below 50-day moving average to 54.90 at 10:04 BST
  • GENI:STO trading volume exceeds daily average by +16.79%

Key statistics

On Friday, Generic Sweden AB (publ) (GENI:STO) closed at 59.90, 46.10% above the 52 week low of 41.00 set on Mar 07, 2022.
52-week range
Today
41.00Mar 07 2022127.40Sep 27 2021
Markit short selling activity
Low
Med
High
Open58.40
High61.50
Low58.20
Bid--
Offer--
Previous close58.00
Average volume8.13k
Shares outstanding12.29m
Free float12.17m
P/E (TTM)40.62
Market cap736.29m SEK
EPS (TTM)1.47
SEK
Annual div (ADY)1.00
SEK
Annual div yield (ADY)1.67%
Div ex-dateMay 19 2022
Div pay-dateMay 25 2022
Data delayed at least 15 minutes, as of May 20 2022 17:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.